naa a22 4500 510779174 CHVBK 20180411083241.0 cr unu---uuuuu 180411e20130201xx s 000 0 eng 10.1007/s11892-012-0340-1 doi (NATIONALLICENCE)springer-10.1007/s11892-012-0340-1 Glycemic Management in Medical and Surgical Patients in the Non-ICU Setting [Elektronische Daten] [Kara Hawkins, Amy Donihi, Mary Korytkowski] Hyperglycemia is commonly observed in hospitalized patients with and without previously known diabetes and is associated with adverse outcomes. For this reason, measurement of blood glucose (BG) is recommended for all patients at admission. Measurement of an A1C identifies patients with either newly recognized diabetes or uncontrolled diabetes. Current guidelines advise fasting and premeal BG <140mg/dl, with maximal random BG <180mg/dl for the majority of noncritically ill patients. Rational use of basal bolus insulin (BBI) regimens is effective in achieving these glycemic goals, with low risk for hypoglycemia. The safety of BBI relies upon provider knowledge for initiation and adjustment of insulin doses for changes in nutritional status or use of medications affecting glucose metabolism. Smooth transition of care to the outpatient setting is facilitated by providing oral and written instructions regarding timing and dosing of insulin, as well as education in basic skills for home management. Springer Science+Business Media New York, 2012 Type 1 diabetes nationallicence Type 2 diabetes nationallicence Hyperglycemia nationallicence Inpatients nationallicence Insulin nationallicence Perioperative care nationallicence Continuity of patient care nationallicence Glycemic management nationallicence Medical and surgical patients nationallicence Non-ICU setting nationallicence BBI : Basal-bolus insulin nationallicence BG : Blood glucose nationallicence CSII : Continuous subcutaneous insulin infusion nationallicence DKA : Diabetic ketoacidosis nationallicence IDMP : inpatient diabetes management program nationallicence IV : Intravenous nationallicence POC : Point of care nationallicence SSI : Sliding scale insulin nationallicence RISS : regular insulin sliding scale nationallicence TGMP : Targeted glycemic management program nationallicence TDD : Total daily dose nationallicence Hawkins Kara Division of Endocrinology, Department of Medicine, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA aut Donihi Amy School of Pharmacy, Department of Pharmacy and Therapeutics, University of Pittsburgh, Pittsburgh, PA, USA aut Korytkowski Mary Division of Endocrinology, Department of Medicine, University of Pittsburgh Medical Center, Falk, Room 560, 3601 Fifth Avenue, 15213, Pittsburgh, PA, USA aut Current Diabetes Reports Current Science Inc. 13/1(2013-02-01), 96-106 1534-4827 13:1<96 2013 13 11892 https://doi.org/10.1007/s11892-012-0340-1 text/html Onlinezugriff via DOI 1 review-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s11892-012-0340-1 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Hawkins Kara Division of Endocrinology, Department of Medicine, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA aut NATIONALLICENCE 700 1- Donihi Amy School of Pharmacy, Department of Pharmacy and Therapeutics, University of Pittsburgh, Pittsburgh, PA, USA aut NATIONALLICENCE 700 1- Korytkowski Mary Division of Endocrinology, Department of Medicine, University of Pittsburgh Medical Center, Falk, Room 560, 3601 Fifth Avenue, 15213, Pittsburgh, PA, USA aut NATIONALLICENCE 773 0- Current Diabetes Reports Current Science Inc 13/1(2013-02-01), 96-106 1534-4827 13:1<96 2013 13 11892 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer